NYSE:ALX
NYSE:ALXRetail REITs

Assessing Alexander’s (ALX) Valuation After Recent Share Price Momentum

Alexander's (ALX) has attracted fresh attention after its recent share performance, with a 0.7% move over the past day and a 3.4% gain over the past week. This has prompted a closer look at fundamentals. See our latest analysis for Alexander's. That recent 1-day share price return of 0.7% and 7-day share price return of 3.4% sit alongside a 30-day share price return of 6.8%, a 90-day share price decline of 5.9% and a 1-year total shareholder return of 29.9%. Taken together, these figures...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Has Johnson & Johnson (JNJ) Run Too Far After Its 44.3% One-Year Surge?

Wondering if Johnson & Johnson is still a solid price for a long-term holding or if the recent run has moved it too far, too fast? This article focuses squarely on what you are getting for the price you pay. The stock last closed at US$204.79, with a 7-day return of a 1% decline, a 30-day return of 1.4%, a year-to-date return of a 1.2% decline, and a 1-year return of 44.3% that sits well above the 3-year and 5-year returns of 28.1% and 49.3%. Recent headlines around Johnson & Johnson have...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Is Teva Pharmaceutical Industries (TEVA) Still Attractive After A 49% One Year Share Price Jump

If you are wondering whether Teva Pharmaceutical Industries at around US$32.11 is offering good value today, you will want to look past the headlines and into how its current price lines up with different valuation checks. The stock has posted returns of 2.5% over the last 7 days, 12.8% over the past month, 3.7% year to date and 48.7% over the past year, with a 3 year return of 192.2% and a 5 year return of 174.0%. This naturally raises questions about what is already baked into the...